3, IL-6, granulocyte-macrophage colony-stimulating factor, and EPA, either singly or in association.' The defect stems from the inability of multipotent progenitors to undergo erythroid differentiation, whereas granulocyte, macrophage, and megakaryocyte proliferation and differentiation are normaL7 Addition of stem-cell factor (SCF) to IL-3 and EPO significantly increases the number and size of erythroid culture~.~"" A similar pattern is observed in Steel mice, which have a clinical phenotype similar to that of humans with DBA and carry deletions and point mutations within the Steel gene, the murine analog of the SCF gene."." However, the finding that the SCF transcript is normal both in quantity and in sequence in several DBA patients indicates that SCF itself is not directly inv~lved.'~''.'~ Moreover, mutations in the SCF receptor c-kit have been identified in human piebaldism, a disease not associated with hematologic abnormalities."
DBA patients display an impaired in vivo and in vitro response to pharmacologic doses of EP0.7,1b.'7 Serum EPO concentration is also high in proportion to the severity of anemia.' However, the structure of EPO is normal and anti-EPO antibodies are absent,2 and hence abnormalities in EPO receptor (EPO-R) expression, EPO binding, or EPO signal transduction may be present. Abnormal EPO-R function, in fact, has been speculatively advanced as a cause of DBA.'X.'q The present report describes an investigation of this suggestion through screening of the coding sequence of the EPO-R gene for mutations in 23 DBA patients. Linkage of the EPO-R gene with the clinical phenotype of DBA was also evaluated in seven families with at least two siblings.
MATERIALS AND METHODS

Patients.
Twenty-three patients with DBA (including two sisters) and all their available relatives were studied. Twenty-one patients were white, one was black (patient no. 9), and one was of East Indian origin (patient no. 8). Thirteen were Italian or of Italian origin, and eight were Canadian. All families were unrelated.
Diagnosis was based on the following criteria': ( I ) normochromic anemia in early infancy, (2) reticulocytopenia, ( 3 ) normocellular bone m m o w with selective deficiency of red blood cell precursors, (4) normal or shghtly decreased leukocyte counts, and (S) normal or often increased platelet counts. The clinical data are listed in Table I Two SSCP protocols were used to reveal all the possible DNA respond during a clinical trial with E-3, whereas patients no. 17 changes. The first permits detection of heteroduplex shifts, as well and 22 displayed a partial or transient response.' Red blood cell as SSCP, and thus allows a further way of identifying mutations. adenosine deaminase levels in patients no. 16, 17, 19, 20, and 21 Labeled DNA strands were obtained by addition of 1 pL [3ss]dATP were 1.48, 1.35, 2.3, 5, and 3 U/g hemoglobin, respectively (normal (3,000 Ci/mmoVL; Amersham International, Amersham, UK) and range, 0.9 to 1.3). 0.5 U Tay polymerase to one tenth of the PCR products and perThere were no family histories suggesting a dominant inheritance.
forming another five PCR cycles. Half the labeled PCR reactions Recessive inheritance was indicated in three families by the presence of three affected sisters (patients no. 1 and 2, whose other affected sister died in infancy), an affected cousin (patient no. 17), and consanguineous parents (patient no. 8). All other cases were sporadic according to history. Seven families (of patients no. 1 to 3, 5, 19, 20.21, and 22) had unaffected siblings with normal peripheral blood films and normal hematology.
Screening for murutions. Lymphocytes were isolated by Ficoll separation from 10 mL peripheral blood. Cells were expanded by incubation with phytohemoagglutinin and recombinant IL-2. Aliyuots of IO6 cells were subjected to DNA extraction by standard procedures or stored in liquid nitrogen for further amplification.
The entire EPO-R gene coding sequence for 23 patients was screened using genomic DNA polymerase chain reaction (PCR). amplified with the primers listed in Table 2 .20-26 These were derived from intron DNA sequences flanking exons 1 to 8. Exon 8 was amplified in three overlapping segments. PCR products of 200 to 300 bp were obtained to permit adequate resolution of single DNA strands in single-strand conformation polymorphism (SSCP) gels.27 The approach used to amplify the EPO-R gene is shown in Fig 1. were then added to 20 pL 0.1% sodium dodecyl sulfate and 10 mmol/L EDTA, pH 8. One fifth of this solution was added to an identical volume of 95% formamide, 20 mmoK EDTA, pH 8, 0.05% xylene cyanol, and 0.05% bromophenol blue. The samples were heated to 95°C for S minutes and loaded onto 40-cm long, 5% to 8% polyacrylamide gels in the presence of 5% glycerol in 0.5X TBE buffer. The gels were electrophoresed at 26W for 3 hours at 4"C, dried on Whatman 3 " paper (Maidstone, UK), and exposed on Kodak AR films (Eastman Kodak, Rochester, NY) for 2 to 6 days. Each autoradiograph was inspected for band shifts. Exons with shifts were sequenced with the Sequenase Version 2.0 kit (US Biochemical Corp, Cleveland, OH) after purification of PCR amplification products with the Qiaex kit (Qiagen, Chatsworth, CA).
All exons were also studied using a nonradioactive SSCP protocol. Twenty microliters of 0.1% sodium dodecyl sulfate and IO mmol/ L EDTA, pH 8, were added to half the unlabeled PCR reactions. One fifth of the solution was added to an identical volume of 95% formamide, 20 mmol/L EDTA, pH 8, 0.05% xylene cyanol, and 0.05% bromophenol blue. The samples were heated to 95°C for 5 minutes and loaded onto 10-cm long, 0.6% MDE gels (Hydrolink- MDE AT Biochem, Malvern, PA) in 0.6X TBE buffer. The gels were electrophoresed at 26W for 3 hours at room temperature. DNA bands were visualized by silver staining: gels were incubated for 30 minutes in a solution containing 0.3% NaOH, 0.3% ammonia, and 0.3% silver nitrate, washed three times for S minutes in distilled water, and developed in a solution containing 0.005% citric acid and 0.02% formaldehyde. Reactions were stopped by washing in distilled water. Gels were then inspected for band shifts and photographed. All samples showing abnormal shifts were purified with the Qiaex kit and sequenced with the Sequenase Version 2.0 kit.
Linkage studies. Segregation of the EPO-R gene was analyzed in families with at least two siblings. One family had two siblings with DBA (the family of patients no. 1 and 2). and six families had one individual with DBA and at least one unaffected sibling (families of patients no. the appropriate primerszx were loaded onto 20 X 40-cm 8% acrylamide gels and electrophoresed for 18 hours at 300 to 400 V. The gels were then silver-stained as described earlier. This procedure does not allow exact definition of the PCR product length, but optimally traces the segregation of paternal and maternal alleles. Southern blot ana/ysis. This analysis was used to determine whether the DBA phenotype was due to gross rearrangements of the EPO-R gene. High-molecular-weight genomic DNA was prepared from patients no. l , 2, S, 9, 21, 22, and 23. Ten micrograms of each DNA was digested to completion with the restriction endonuclease BamHl fractionated by electrophoresis in a 0.8% agarose gel, transferred to Hybond N filter (Amersham International, Amersham, UK), and hybridized with a "P-labeled human EPO-R fragment generated by PCR amplification using primers S and V ( Table 2) . with a human EPO-R cDNA clone ( I O ng) as the substrate. Twenty PCR cycles were run in the presence of 0.4 pmolk "P-dCTP and I pmol/L of the three remaining deoxynucleotides. The PCR product was 462-bp long and encompassed most of exon 8. This approach screens the EPO-R gene region between one BamHl site upstream from exon 3 and another within the 3' untranslated region."' A G-to-T change was observed in exon 2 at codon 56 in patient no. 9, in heterozygosity with the normal sequence. This substitution does not change the translated arginine (CGG to CGT) and is thus a silent mutation. The change was confirmed by restriction digestion with HpaII on a PCR product obtained using a mutagenesis primer.
RESULTS
Screening for mutations and
A shift in exon 5, again in patient no. 9, corresponds to a C-to-A substitution at codon 219. This change was also confirmed in the same way. It, too, does not alter the encoded alanine (GCC to GCA), but may give rise to an alternative consensus acceptor splice site with a high score (84.6) according to the formula proposed by Shapiro and Senapathy.3' To determine whether this new splice site was used, we sequence,z2.23.25 A second change was observed at position extracted total RNA from peripheral lymphocytes obtained from patient no. 9 and retrotranscribed an exonic region encompassing the mutation by using primer K. A nested PCR was performed because a low rate of transcription was expected from lymphocytes (ectopic transcription). The first round of PCR was performed using primer Z , mapping in exon 3, and primer K, mapping in exon 6, and the second round using primer W, mapping in exon 4, and primer Y, mapping in exon 5. Normal individuals and patient no. 9 displayed identical 203-bp PCR products in several experiments, showing that the canonic splice site of exon 5 was always used and that the change at codon 219 is indeed a silent mutation. No gross EPO-R gene alteration was revealed by Southern blot analysis.
Linknge stcrdies. Inheritance of the EPO-R gene was evaluated in seven families with more than one sibling. Family B with two affected daughters (patients no. 1 and 2) ruled out segregation of DBA with the EPO-R gene. The parents are compound heterozygotes for different alleles of this highly polymorphic marker, and the two affected daughters display inheritance of different alleles (Fig 2) . The parents of patient no. 22 (family A) are also compound heterozygotes for different alleles. The finding of an identical pattern of EPO-R alleles in three normal siblings and in the patient with DBA rules out a linkage of the EPO-R gene and the phenotype of DBA in this family (Fig 2) .
In all the other families, segregation of the EPO-R gene could be concordant with DBA inheritance. Patient no. 3 and his normal sibling have inherited different alleles. Patients no. 5 , 19, 20, and 21 share an allele with a single unaffected sibling. retention of the positive regulatory domain in the COOHterminal region, with the result that the mutated protein excessively stimulates erythropoiesis. A similar mechanism has been proposed for sporadic polycythemia, but so far no causal mutation has been identified." The question of EPO-R gene mutations in DBA has not been previously considered.
We reasoned that mutations in the positive regulatory domain of exon 8, as well as mutations affecting a consensus sequence essential for transduction of the receptor signal, such as those constructed by in vitro might explain the phenotype of DBA.
Coding regions of the EPO-R gene were screened by SSCP in 23 DBA patients in a search for such mutations. One patient displayed band shifts in exons 2 and 5 corresponding to DNA mutations not associated with a change in amino acid sequence. Several patients displayed three additional band shifts in the fragment encompassing exon 1. One of these corresponds to a previously reported variant sequence,'"'' whereas the other two changes observed in several patients do not affect any known transcriptional protein binding site. The future production of animals transgenic for these changes will perhaps illustrate their relationship to the DBA phenotype. However, they cannot be regarded as candidate mutations. Moreover, no gross rearrangement of the EPO-R gene was disclosed by Southern blotting, and linkage analysis did not reveal an association between the EPO-R gene and DBA in two informative families.
These data demonstrate that mutations in the EPO-R gene on chromosome 19 are not commonly associated with DBA. A second protein, encoded by a different gene, is thought to be involved in the functional EPO-R complex.'" The extent to which this complex is involved in the pathogenesis of DBA thus requires further investigation via analysis of signal transduction after stimulation"." and EPO-bound protein patterns"" in erythroid precursors.
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